Report Cover

United States Gaucher Disease Market Report & Forecast 2021-2027


United States Gaucher Disease Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Gaucher Disease Market Segment Percentages, By Type, 2020 (%)
    Enzyme Replacement Therapy
    Substrate Reduction Therapy

United States Gaucher Disease Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Gaucher Disease Market Segment Percentages, By Application, 2020 (%)
    Non-neuronopathic Gaucher Disease
    Neuronopathic Gaucher Disease

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gaucher Disease revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Gaucher Disease revenues share in United States market, 2020 (%)
Key companies Gaucher Disease sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Gaucher Disease sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi
    Takeda
    Actelion Pharma
    Pfizer (Protalix)
    ISU ABXIS
1 Introduction to Research & Analysis Reports
    1.1 Gaucher Disease Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Gaucher Disease Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Gaucher Disease Overall Market Size
    2.1 United States Gaucher Disease Market Size: 2021 VS 2027
    2.2 United States Gaucher Disease Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Gaucher Disease Sales: 2016-2027

3 Company Landscape
    3.1 Top Gaucher Disease Players in United States Market
    3.2 Top United States Gaucher Disease Companies Ranked by Revenue
    3.3 United States Gaucher Disease Revenue by Companies
    3.4 United States Gaucher Disease Sales by Companies
    3.5 United States Gaucher Disease Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Gaucher Disease Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Gaucher Disease Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Gaucher Disease Players in United States Market
        3.8.1 List of Tier 1 Gaucher Disease Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Gaucher Disease Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Gaucher Disease Market Size Markets, 2021 & 2027
        4.1.2 Enzyme Replacement Therapy
        4.1.3 Substrate Reduction Therapy
    4.2 By Type - United States Gaucher Disease Revenue & Forecasts
        4.2.1 By Type - United States Gaucher Disease Revenue, 2016-2021
        4.2.2 By Type - United States Gaucher Disease Revenue, 2022-2027
        4.2.3 By Type - United States Gaucher Disease Revenue Market Share, 2016-2027
    4.3 By Type - United States Gaucher Disease Sales & Forecasts
        4.3.1 By Type - United States Gaucher Disease Sales, 2016-2021
        4.3.2 By Type - United States Gaucher Disease Sales, 2022-2027
        4.3.3 By Type - United States Gaucher Disease Sales Market Share, 2016-2027
    4.4 By Type - United States Gaucher Disease Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Gaucher Disease Market Size, 2021 & 2027
        5.1.2 Non-neuronopathic Gaucher Disease
        5.1.3 Neuronopathic Gaucher Disease
    5.2 By Application - United States Gaucher Disease Revenue & Forecasts
        5.2.1 By Application - United States Gaucher Disease Revenue, 2016-2021
        5.2.2 By Application - United States Gaucher Disease Revenue, 2022-2027
        5.2.3 By Application - United States Gaucher Disease Revenue Market Share, 2016-2027
    5.3 By Application - United States Gaucher Disease Sales & Forecasts
        5.3.1 By Application - United States Gaucher Disease Sales, 2016-2021
        5.3.2 By Application - United States Gaucher Disease Sales, 2022-2027
        5.3.3 By Application - United States Gaucher Disease Sales Market Share, 2016-2027
    5.4 By Application - United States Gaucher Disease Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Overview
        6.1.3 Sanofi Gaucher Disease Sales and Revenue in United States Market (2016-2021)
        6.1.4 Sanofi Gaucher Disease Product Description
        6.1.5 Sanofi Recent Developments
    6.2 Takeda
        6.2.1 Takeda Corporation Information
        6.2.2 Takeda Overview
        6.2.3 Takeda Gaucher Disease Sales and Revenue in United States Market (2016-2021)
        6.2.4 Takeda Gaucher Disease Product Description
        6.2.5 Takeda Recent Developments
    6.3 Actelion Pharma
        6.3.1 Actelion Pharma Corporation Information
        6.3.2 Actelion Pharma Overview
        6.3.3 Actelion Pharma Gaucher Disease Sales and Revenue in United States Market (2016-2021)
        6.3.4 Actelion Pharma Gaucher Disease Product Description
        6.3.5 Actelion Pharma Recent Developments
    6.4 Pfizer (Protalix)
        6.4.1 Pfizer (Protalix) Corporation Information
        6.4.2 Pfizer (Protalix) Overview
        6.4.3 Pfizer (Protalix) Gaucher Disease Sales and Revenue in United States Market (2016-2021)
        6.4.4 Pfizer (Protalix) Gaucher Disease Product Description
        6.4.5 Pfizer (Protalix) Recent Developments
    6.5 ISU ABXIS
        6.5.1 ISU ABXIS Corporation Information
        6.5.2 ISU ABXIS Overview
        6.5.3 ISU ABXIS Gaucher Disease Sales and Revenue in United States Market (2016-2021)
        6.5.4 ISU ABXIS Gaucher Disease Product Description
        6.5.5 ISU ABXIS Recent Developments

7 United States Gaucher Disease Production Capacity, Analysis
    7.1 United States Gaucher Disease Production Capacity, 2016-2027
    7.2 Gaucher Disease Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Gaucher Disease Supply Chain Analysis
    9.1 Gaucher Disease Industry Value Chain
    9.2 Gaucher Disease Upstream Market
    9.3 Gaucher Disease Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Gaucher Disease Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Gaucher Disease in United States Market Table 2. Top Gaucher Disease Players in United States Market, Ranking by Revenue (2019) Table 3. United States Gaucher Disease Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Gaucher Disease Revenue Share by Companies, 2016-2021 Table 5. United States Gaucher Disease Sales by Companies, (K Units), 2016-2021 Table 6. United States Gaucher Disease Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Gaucher Disease Price (2016-2021) & (USD/Unit) Table 8. Manufacturers Gaucher Disease Product Type Table 9. List of Tier 1 Gaucher Disease Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Gaucher Disease Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Enzyme Replacement Therapy Table 12. Major Manufacturers of Substrate Reduction Therapy Table 13. By Type - United States Gaucher Disease Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Gaucher Disease Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Gaucher Disease Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Gaucher Disease Sales (K Units), 2016-2021 Table 17. By Type - United States Gaucher Disease Sales (K Units), 2022-2027 Table 18. By Application - United States Gaucher Disease Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Gaucher Disease Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Gaucher Disease Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Gaucher Disease Sales (K Units), 2016-2021 Table 22. By Application - United States Gaucher Disease Sales (K Units), 2022-2027 Table 23. Sanofi Corporation Information Table 24. Sanofi Description and Major Businesses Table 25. Sanofi Gaucher Disease Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 26. Sanofi Gaucher Disease Product Table 27. Sanofi Recent Developments Table 28. Takeda Corporation Information Table 29. Takeda Description and Major Businesses Table 30. Takeda Gaucher Disease Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 31. Takeda Gaucher Disease Product Table 32. Takeda Recent Developments Table 33. Actelion Pharma Corporation Information Table 34. Actelion Pharma Description and Major Businesses Table 35. Actelion Pharma Gaucher Disease Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 36. Actelion Pharma Gaucher Disease Product Table 37. Actelion Pharma Recent Developments Table 38. Pfizer (Protalix) Corporation Information Table 39. Pfizer (Protalix) Description and Major Businesses Table 40. Pfizer (Protalix) Gaucher Disease Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 41. Pfizer (Protalix) Gaucher Disease Product Table 42. Pfizer (Protalix) Recent Developments Table 43. ISU ABXIS Corporation Information Table 44. ISU ABXIS Description and Major Businesses Table 45. ISU ABXIS Gaucher Disease Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021) Table 46. ISU ABXIS Gaucher Disease Product Table 47. ISU ABXIS Recent Developments Table 48. Gaucher Disease Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units) Table 49. United States Gaucher Disease Capacity Market Share of Key Manufacturers, 2019-2021 Table 50. Gaucher Disease Market Opportunities & Trends in United States Market Table 51. Gaucher Disease Market Drivers in United States Market Table 52. Gaucher Disease Market Restraints in United States Market Table 53. Gaucher Disease Raw Materials Table 54. Gaucher Disease Raw Materials Suppliers in United States Market Table 55. Typical Gaucher Disease Downstream Table 56. Gaucher Disease Downstream Clients in United States Market Table 57. Gaucher Disease Distributors and Sales Agents in United States Market List of Figures Figure 1. Gaucher Disease Product Picture Figure 2. Gaucher Disease Segment by Type Figure 3. Gaucher Disease Segment by Application Figure 4. United States Gaucher Disease Market Overview: 2020 Figure 5. United States Gaucher Disease Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Gaucher Disease Revenue, 2016-2027 (US$, Mn) Figure 7. Gaucher Disease Sales in United States Market: 2016-2027 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Gaucher Disease Revenue in 2020 Figure 9. Enzyme Replacement Therapy Product Picture Figure 10. Substrate Reduction Therapy Product Picture Figure 11. By Type - United States Gaucher Disease Sales Market Share, 2016-2027 Figure 12. By Type - United States Gaucher Disease Revenue Market Share, 2016-2027 Figure 13. By Type - United States Gaucher Disease Price (USD/Unit), 2016-2027 Figure 14. Non-neuronopathic Gaucher Disease Figure 15. Neuronopathic Gaucher Disease Figure 16. By Application - United States Gaucher Disease Sales Market Share, 2016-2027 Figure 17. By Application - United States Gaucher Disease Revenue Market Share, 2016-2027 Figure 18. By Application - United States Gaucher Disease Price (USD/Unit), 2016-2027 Figure 19. Sanofi Gaucher Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 20. Takeda Gaucher Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Actelion Pharma Gaucher Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Pfizer (Protalix) Gaucher Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. ISU ABXIS Gaucher Disease Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. United States Gaucher Disease Production Capacity (K Units), 2016-2027 Figure 25. Gaucher Disease Industry Value Chain Figure 26. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us